Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Brain : a journal of neurology

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/brain/awr278PMID 22171355PMCID PMC3235560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia.

  2011cited by this paper
• T2*-based fiber orientation mapping

  2011cited by this paper
• Iron and the immune system

  2011cited by this paper
• Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions

  2011cited by this paper
• Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast

  2010cited by this paper
• On the contribution of deoxy-hemoglobin to MRI gray-white matter phase contrast at high field

  2010cited by this paper
• High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

  2010cited by this paper
• Relationship between brain R2 and liver and serum Iron concentrations in elderly men

  2010cited by this paper
• Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging.

  2010cited by this paper
• Double Inversion Recovery MRI with Fat Suppression at 7 Tesla: Initial Experience

  2010cited by this paper
• High‐Resolution Phased‐Array MRI of the Human Brain at 7 Tesla: Initial Experience in Multiple Sclerosis Patients

  2010cited by this paper
• 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions

  2010cited by this paper
• Susceptibility tensor imaging

  2010cited by this paper
• Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure (vol 107, pg 5130, 2010)

  2010cited by this paper
• Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure

  2010cited by this paper
• The effect of formalin fixation on the levels of brain transition metals in archived samples

  2010cited by this paper
• Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis

  2010cited by this paper
• Susceptibility contrast in high field MRI of human brain as a function of tissue iron content

  2009cited by this paper
• Towards an in-vivo and post-mortem characterization of chronic multiple sclerosis lesions using susceptibility related mechanisms of contrast at ultra-high field MRI with R2* and phase images

  2009cited by this paper
• A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS Lesions

  2009cited by this paper
• Characterization of T2* heterogeneity in human brain white matter

  2009cited by this paper
• Oligodendrocytes and myelination: The role of iron

  2009cited by this paper
• Biophysical mechanisms of phase contrast in gradient echo MRI

  2009cited by this paper
• Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study.

  2009cited by this paper
• High field MRI in the diagnosis of multiple sclerosis: high field–high yield?

  2009cited by this paper
• Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data

  2009cited by this paper
• Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

  2009cited by this paper
• Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis.

  2008cited by this paper
• Multiple sclerosis and Alzheimer's disease

  2008cited by this paper
• Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases

  2008cited by this paper
• Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity

  2008cited by this paper
• The pathologic substrate of magnetic resonance alterations in multiple sclerosis.

  2008cited by this paper
• Leaching of Trace Elements from Biological Tissue by Formalin Fixation

  2008cited by this paper
• Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

  2008cited by this paper
• DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI

  2008cited by this paper
• High-field MRI of brain cortical substructure based on signal phase

  2007cited by this paper
• Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review.

  2007cited by this paper
• Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease

  2007cited by this paper
• Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients

  2007cited by this paper
• The Immunopathology of Multiple Sclerosis: An Overview

  2007cited by this paper
• Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.

  2006cited by this paper
• Measurement and Mapping of Liver Iron Concentrations Using Magnetic Resonance Imaging

  2005cited by this paper
• The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis

  2004cited by this paper
• Enhanced gray and white matter contrast of phase susceptibility‐weighted images in ultra‐high‐field magnetic resonance imaging

  2003cited by this paper
• Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.

  2003cited by this paper
• Immunopathology of secondary‐progressive multiple sclerosis

  2001cited by this paper
• MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.

  1999cited by this paper
• Cellular distribution of iron in the brain of the Belgrade rat.

  1999cited by this paper
• Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism.

  1997cited by this paper
• Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

  1997cited by this paper
• Diagnostic criteria for the neuropathologic assessment of Alzheimer's disease.

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• The effect of histological processing on the form of iron in iron-loaded human tissues.

  1997cited by this paper
• The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry.

  1996cited by this paper
• Relationship of iron to oligodendrocytes and myelination.

  1996cited by this paper
• Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths.

  1995cited by this paper
• A histochemical study of iron‐positive cells in the developing rat brain

  1995cited by this paper
• Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths.

  1990cited by this paper
• Do oligodendrocytes mediate iron regulation in the human brain?

  1989cited by this paper
• MR imaging of compact white matter pathways.

  1988cited by this paper
• Perivascular iron deposition and other vascular damage in multiple sclerosis.

  1988cited by this paper
• MRI of brain iron.

  1986cited by this paper
• Iron deposits and multiple sclerosis.

  1984cited by this paper
• Iron deposits surrounding multiple sclerosis plaques.

  1982cited by this paper
• ON THE VESSEL‐PLAQUE RELATIONSHIPS IN THE BRAIN IN MULTIPLE SCLEROSIS

  1964cited by this paper
• ON THE VESSEL‐PLAQUE RELATIONS IN THE BRAIN IN MULTIPLE SCLEROSIS

  1963cited by this paper
• Über den eisennachweis im gehirn, besonders in zentren des extrapyramidal-motorischen systems. I. Teil

  1922cited by this paper

• Iron-Rim Lesions in the Optic Chiasm in Multiple Sclerosis

  2026cites this paper
• Topographical Variation of Iron‐Rimmed Lesions in the Multiple Sclerosis Brain and Spinal Cord: A Neuropathological Study

  2026cites this paper
• Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion

  2025cites this paper
• Demyelinated lesion associated compartmental inflammation in progressive multiple sclerosis brains

  2025influential citation
• Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis

  2025cites this paper
• Labile iron overload reprograms microglia and neurons for lipid droplet synthesis in the aging brain

  2025cites this paper
• Quantitative susceptibility mapping is more sensitive and specific than phase imaging in detecting chronic active multiple sclerosis lesion rims: pathological validation

  2025cites this paper
• Paramagnetic rim lesions in early multiple sclerosis: a 7 Tesla imaging study.

  2025cites this paper
• Determinants driving the evolution of new multiple sclerosis lesions into chronic active or remyelinated states

  2025cites this paper
• The role of susceptibility weighted imaging as a substitute to post-contrast T1-weighed images in detection of active multiple sclerosis lesions.

  2025cites this paper
• Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside

  2025cites this paper
• Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic

  2025cites this paper
• T2 contrast variation in human brain at 7 T and its potential contributors

  2025cites this paper
• The Dual Role of Microglia in Multiple Sclerosis and its Implications for Diagnostics and Repair

  2025cites this paper
• Artificial Intelligence in Multiple Sclerosis: Possibilities in Radiological Diagnostics and Progression Assessment

  2025cites this paper
• Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disorder by 7.0 Tesla MRI

  2025cites this paper
• Immunosenescence in multiple sclerosis: New insights and clinical implications

  2025cites this paper
• 7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine

  2025cites this paper
• Cyclooxygenase-1 and cyclooxygenase-2 densities measured using positron emission tomography are not altered in the brains of individuals with stable multiple sclerosis

  2025cites this paper
• The 2024 Update to the McDonald Criteria for Multiple Sclerosis Diagnosis: A Guide for Radiologists.

  2025cites this paper
• Epilepsy associated with multiple sclerosis (сurrent state of the problem)

  2025cites this paper
• Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy

  2025cites this paper
• Iron–Immune Crosstalk at the Maternal–Fetal Interface: Emerging Mechanisms in the Pathogenesis of Preeclampsia

  2025cites this paper
• The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

  2024cites this paper
• Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role

  2024cites this paper
• Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

  2024cites this paper
• Paramagnetic rim lesions as a biomarker to discriminate between multiple sclerosis and cerebral small vessel disease

  2024cites this paper
• Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions

  2024cites this paper
• Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis

  2024cites this paper
• Pooled analysis of multiple sclerosis findings on multisite 7 Tesla MRI: Protocol and initial observations

  2024cites this paper
• Iron scavenging and myeloid cell polarization.

  2024cites this paper
• Longitudinal myelin content measures of slowly expanding lesions using 7T MRI in multiple sclerosis

  2024cites this paper
• Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance

  2024cites this paper
• Imaging of the superficial white matter in health and disease

  2024influential citation
• Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions

  2024cites this paper
• Chronic active lesions preferentially localize in watershed territories in multiple sclerosis

  2024cites this paper
• The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosis.

  2024cites this paper
• Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation

  2024cites this paper
• Longitudinal Changes in Iron and Myelination Within Ischemic Lesions Associate With Neurological Outcomes: A Pilot Study

  2024cites this paper
• QSM-RimDS: A detection and segmentation tool for paramagnetic rim lesions in multiple sclerosis

  2024cites this paper
• Slowly expanding lesions are associated with disease activity and gray matter loss in relapse‐onset multiple sclerosis

  2024cites this paper
• Radiomics derived from T2-FLAIR: the value of 2- and 3-classification tasks for different lesions in multiple sclerosis

  2024cites this paper
• The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis

  2024cites this paper
• New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein Sign.

  2024cites this paper
• The Iron Maiden: Oligodendroglial metabolic disfunction in multiple sclerosis and mitochondrial signalling.

  2024cites this paper
• Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim Lesions

  2024cites this paper
• Role of NRF2 in Pathogenesis of Alzheimer’s Disease

  2024cites this paper
• Imaging chronic active lesions in multiple sclerosis: a consensus statement.

  2024cites this paper
• Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms

  2023cites this paper
• Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review

  2023cites this paper
• Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis

  2023cites this paper
• CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS

  2023cites this paper
• Comparing RNA-sequencing datasets from astrocytes, oligodendrocytes, and microglia in multiple sclerosis identifies novel dysregulated genes relevant to inflammation and myelination.

  2023cites this paper
• Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?

  2023cites this paper
• Evaluation of the Blood‐Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI

  2023cites this paper
• Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China

  2023cites this paper
• Mechanisms of Neurodegeneration in Multiple Sclerosis

  2023cites this paper
• Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis

  2023cites this paper
• Cell specificity of Manganese-enhanced MRI signal in the cerebellum

  2023cites this paper
• Roles and regulation of microglia activity in multiple sclerosis: insights from animal models

  2023cites this paper
• A Suggested Mechanism for Green Discoloration of the Postmortem Brain

  2023cites this paper
• Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis.

  2023cites this paper
• Bruton’s tyrosine kinase as a promising therapeutic target for multiple sclerosis

  2023cites this paper
• Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis

  2023cites this paper
• Emerging imaging and liquid biomarkers in multiple sclerosis

  2023cites this paper
• Quantitative susceptibility mapping (QSM) in deep gray matter as a neurodegeneration marker in relapsing-remitting and secondary-progressive multiple sclerosis

  2023cites this paper
• Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions

  2023cites this paper
• Paramagnetic rim lesions and the central vein sign: Characterizing multiple sclerosis imaging markers

  2023cites this paper
• Susceptibility-weighted image features in AQP4-negative-NMOSD versus MS.

  2023cites this paper
• New insight on microglia activation in neurodegenerative diseases and therapeutics

  2023cites this paper
• Cervical spinal cord susceptibility-weighted MRI at 7T: Application to multiple sclerosis

  2023cites this paper
• Deeply 3D-T1-TFE hypointense voxels are characteristic of phase-rim lesions in multiple sclerosis

  2023influential citation
• Are highly active and aggressive multiple sclerosis the same entity?

  2023cites this paper
• Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis

  2023cites this paper
• Quantitative susceptibility mapping for differentiating multiple sclerosis from cerebral small vessel disease

  2023cites this paper
• Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination

  2022cites this paper
• Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis

  2022cites this paper
• The mechanistic target of rapamycin as a regulator of metabolic function in oligodendroglia during remyelination.

  2022cites this paper
• SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions

  2022cites this paper
• A Distinct Hibiscus sabdariffa Extract Prevents Iron Neurotoxicity, a Driver of Multiple Sclerosis Pathology

  2022cites this paper
• QSMRim-Net: Imbalance-aware learning for identification of chronic active multiple sclerosis lesions on quantitative susceptibility maps

  2022cites this paper
• Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis

  2022influential citation
• An automated pipeline for extracting histological stain area fraction for voxelwise quantitative MRI-histology comparisons

  2022cites this paper
• Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia

  2022cites this paper
• Neuroinflammation: 2022 update.

  2022cites this paper
• χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.

  2022cites this paper
• Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions

  2022cites this paper
• Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

  2022cites this paper
• Iron deposition in multiple sclerosis: overall load or distribution alteration?

  2022cites this paper
• From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions

  2022cites this paper
• Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis

  2022cites this paper
• A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis

  2022cites this paper
• Microglia in multiple sclerosis: Protectors turn destroyers.

  2022cites this paper
• Advanced spinal cord MRI in multiple sclerosis: Current techniques and future directions

  2022cites this paper
• Quantitative MRI in Multiple Sclerosis: From Theory to Application

  2022cites this paper
• Geochemistry of multiple sclerosis in Finland.

  2022cites this paper
• Myelinated axons are the primary target of hemin-mediated oxidative damage in a model of the central nervous system.

  2022influential citation
• Cerebral Iron Deposition in Neurodegeneration

  2022cites this paper
• Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability.

  2022cites this paper
• Microglia in multiple sclerosis – pathogenesis and imaging

  2022cites this paper